Living donor transplant: wider selection criteria.
The availability of cadaveric donor organs is insufficient for actual needs. The organ demand increases by 20% per year. Living donor transplant (LDT) may be a valid therapeutical alternative provided one uses proper criteria. LDT provides many advantages, like improved patient and organ survival, short waiting time, and the possibility to carefully plan the procedure. Potential risks include perioperative mortality and renal dysfunction in the kidney donor. At present, kidney LDTs in Italy represent 8% of the total, with an organ survival rate of 97% after 1 year (vs 93% for cadaveric transplants) and donors mortality rate of almost null. Most LDTs are performed from kinsmen. Presently, law no. 458, 26 June 1967, is in force in Italy for kidney LDT and law no. 453, 16 December 1999, for liver LDT. The foundations of LDT are, of course, the recipient's condition, the donor's motivation, and the altruism of the donation. It is desirable that in the future an increasing number of LDT be performed, supported by a careful, widespread health education regarding organ donation from living subjects and by the possibility to obtain insurance for the donor, which has been considered but never provided by actual laws.
Splendiani
G
G
Tor Vergata University, Tor Vergata General Hospital, Rome, Italy.
Cipriani
S
S
Valeri
M
M
Torlone
N
N
Vega
A
A
Tullio
T
T
Condò
S
S
Dominijanni
S
S
Casciani
C U
CU
D000818:Animals; D002102:Cadaver; D005060:Europe; D006801:Humans; D007668:Kidney; D019520:Living Donors / Q000706:statistics & numerical data*; D009679:Nuclear Family; D018579:Patient Selection; D011817:Rabbits; D014019:Tissue Donors; D009927:Tissue and Organ Procurement / Q000941:ethics / Q000331:legislation & jurisprudence